Connect with us
– Diulcus, developed by NovaLead Pharma, shows promising results in clinical trials with a 77.20% ulcer closure rate – Approved by CDSCO and partially funded by...
Sitting Dr Behram Pardiwalla, Director Internal Medicines (L-R) Dr Parag Rindani, CEO Maharashtra, Wockhardt Group of Hospitals, Dr Vijay Sharma, Director Regenerative Therapy, Dr Shraddha Deshpande,...
